Appearance of paoproteins of pulmonary surfactant in human amniotic fluid.
We have isolated and partially characterized the protein found in surface-active material from adult human lungs, and have determined the time of appearance of this protein in amniotic fluid. Fluids were drawn at gestational ages from 12 to 44 wk, and were assayed for their concentration of apoprotein by an agglutination immunoassay. Surfactant apoprotein ((defined as that protein which is reproducibly found in purified preparations of surface active material) was usually first detected from 30 to 32 wk gestation, and its concentration increased almost fivefold to a maximum at 37 wk. The change in apoprotein concentration was approximately paralleled by the change in phospholipid concentration. At all gestational ages there was wide variability in both phospholipid and apoprotein concentrations, and the time of appearance of the apoprotein in amniotic fluid differed among fetuses. The results suggest that the presence of surfactant apoprotein in amniotic fluid is coincident with the biochemical and morphological maturation of the fetal lung, and are additional evidence that this apoprotein is cosecreted with the lipids of surface-active material.
D000653:Amniotic Fluid / Q000032:analysis*; D001059:Apoproteins / Q000032:analysis / Q000302:isolation & purification; D055598:Chemical Phenomena; D002621:Chemistry; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005865:Gestational Age; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007231:Infant, Newborn; D007841:Latex Fixation Tests; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000032:analysis* / Q000302:isolation & purification; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis / Q000378:metabolism; D012967:Sodium Dodecyl Sulfate
D001059:Apoproteins; D011663:Pulmonary Surfactants; D012967:Sodium Dodecyl Sulfate